Development of BioVie’s NE3107 Asset Featured by the American Diabetes Association
June 29, 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
BioVie Added to Russell Microcap® Index
June 28, 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
June 25, 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites
June 24, 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKI
June 23, 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie to Present at 31st Annual Oppenheimer Healthcare Conference
March 11, 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Commences Patient Screening in Phase 2 Clinical Trial
March 09, 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
February 19, 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Interview to Air on Bloomberg International on the RedChip Money Report
October 30, 2020 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie to Participate in B. Riley Securities Liver Disease Therapeutics Day on October 29, 2020
October 29, 2020 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...